Abstract:Motivation: Drug-target interactions (DTIs) hold a pivotal role in drug repurposing and elucidation of drug mechanisms of action. While single-targeted drugs have demonstrated clinical success, they often exhibit limited efficacy against complex diseases, such as cancers, whose development and treatment is dependent on several biological processes. Therefore, a comprehensive understanding of primary, secondary and even inactive targets becomes essential in the quest for effective and safe treatments for cancer and other indications. The human proteome offers over a thousand druggable targets, yet most FDA-approved drugs bind to only a small fraction of these targets. Results: This study introduces an attention-based method (called as MMAtt-DTA) to predict drug-target bioactivities across human proteins within seven superfamilies. We meticulously examined nine different descriptor sets to identify optimal signature descriptors for predicting novel DTIs. Our testing results demonstrated Spearman correlations exceeding 0.72 (P < 0.001) for six out of seven superfamilies. The proposed method outperformed fourteen state-of-the-art machine learning, deep learning and graph-based methods and maintained relatively high performance for most target superfamilies when tested with independent bioactivity data sources. We computationally validated 185 676 drug-target pairs from ChEMBL-V33 that were not available during model training, achieving a reasonable performance with Spearman correlation >0.57 (P < 0.001) for most superfamilies. This underscores the robustness of the proposed method for predicting novel DTIs. Finally, we applied our method to predict missing bioactivities among 3492 approved molecules in ChEMBL-V33, offering a valuable tool for advancing drug mechanism discovery and repurposing existing drugs for new indications. Availability and implementation: https://github.com/AronSchulman/MMAtt-DTA.

Identification of Human Protein Drug Targets Homologues with Data Mining

Learning the Drug Target-Likeness of A Protein

Does Drug-Target Have A Likeness?

Prediction of Potential Drug Targets Based on Simple Sequence Properties

Comprehensive Analysis Of Cancer Drugs Based On Human Protein-Protein Interaction Network Profiles Of These Targets

Analysis of protein features and machine learning algorithms for prediction of druggable proteins

Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs

Attention-based approach to predict drug-target interactions across seven target superfamilies

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.

Computer-Aided Drug Target Search

Predicting drug targets based on protein domains.

DrugProtAI: A guide to the future research of investigational target proteins

DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins

Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

Identifying targets for drug discovery using bioinformatics

Drug Target Proteins Prediction with Network Topological Indices

Using Bioinformatics for Drug Target Identification from the Genome

Identification of Anticancer and Anti-inflammatory Drugs from Drug-target Interaction Descriptors by Machine Learning..

A Comparative Chemogenic Analysis for Predicting Drug-Target Pair Via Machine Learning Approaches.

Predicting therapeutic targets with integration of heterogeneous data sources